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Background: Physical activity (PA) plays an important role in the prevention and management of a number of
chronic conditions. Aim: to investigate the evidence for effectiveness of pedometer-driven walking programs to
promote physical activity among patients with musculoskeletal disorders (MSDs).
Method: A comprehensive systematic review was performed using 11 electronic databases up to 20 February
2014. Keywords and MeSH terms included “musculoskeletal disorders”, “walking”, and “pedometer”. Randomized
controlled trials, published in English, that examined the effects of a pedometer-based walking intervention to
increase physical
activity levels and improve physical function and pain in patients with musculoskeletal disorders were included.
Result: Of the 1996 articles retrieved, seven studies ranging in date of publication from 1998 to 2013 met the inclusion
criteria, allowing data extraction on 484 participants with an age range of 40 to 82 years. Interventions lasted from
4 weeks to 12 months and the results across studies showed significant increases in step count (p < 0.05) following the
intervention. Across these studies, there was a mean increase in PA of 1950 steps per day relative to baseline. Four
studies reported improved scores for pain and/or physical function at the intervention completion point relative to
controls.
Conclusion: This study provides strong evidence for the effectiveness of pedometer walking interventions in
increasing PA levels for patients with MSDs. Our findings suggest that a combination of interventions is likely to be
the most effective strategy to maximize health benefits in the short term. Further research should include larger
sample sizes, and longer intervention durations are required to support the role of pedometer walking interventions as
a long term intervention for management of musculoskeletal disorders.
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The worldwide prevalence of musculoskeletal disorders
(MSDs) is reflected in increasing costs, [1-3] occupa-
tional injury, and long term disability [1,2,4,5]. In par-
ticular, musculoskeletal pain constitutes an increasing
problem in the ageing population [6] and is an import-
ant factor underpinning functional limitations [7-9].
Consequently, musculoskeletal disorders have a large
impact on activities at work and home, [7,8] and place
a considerable burden on the health care system [4].
Physical activity (PA) plays an important role in the
prevention and management of a number of chronic* Correspondence: almsu521@student.otago.ac.nz
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reproduction in any medium, provided the orconditions, [10-12] such as cardiovascular disease, [13-15]
diabetes mellitus, [16] and obesity, [17] and has been shown
to reduce premature mortality and improve quality of life
[10] in the general population [10,18]. In recent years a
number of studies have demonstrated the benefits of pro-
moting an increase in PA to reduce pain and improve qual-
ity of life in the adult population with MSDs, [19-21] to
reduce musculoskeletal impairment in the elderly, [20] and
reduce pain for those with low back pain (LBP) [22], neck
pain, and shoulder pain [23]. Physical activity has also been
shown to play a role in protecting against later hip fracture
in an adult population [24] and reducing the incidence of
osteoporotic vertebral fractures in an elderly population
[25]. Results from a systematic review also support the ef-
fectiveness of PA to treat and prevent a number of chronictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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the management of MSDs, and considerable debate about
the most effective interventions; [9] however, increasing PA
as part of the overall management approach is a key feature
of a range of studies investigating the management of
MSDs [9,27].
Walking is deemed to be one of the most effective
forms of PA, with little risk of injury among low-activity
populations; [28-30] it has been used successfully as
an intervention to reduce the burden of a number of
chronic diseases including hypertension, [31] cardiovas-
cular risk, [32] obesity, [33] and osteoarthritis (OA) [34].
Currently, there are a number of studies that support
the use of walking-based interventions to encourage
people with a range of MSDs [22,34] to assume a physic-
ally more active role in their management.
Pedometers have been commonly employed to provide a
measurement of walking undertaken as part of a PA pro-
gram, to provide patient feedback, and as a motivational
instrument within intervention programs designed to
increase activity and improve the quality of life, across
a range of clinical conditions including: chronic ob-
structive pulmonary disease (COPD), [35] diabetes,
[36,37] inactive overweight and obese older people,
[38,39] and healthy adults [40,41]. In addition, a num-
ber of studies describe a variety of pedometer-driven
walking research protocols for adults with low back
pain [42,43] designed to assess the effects on pain-
related disability and functional interference.
A systematic review on the effect of aerobic walking or
strengthening exercises for OA of knee found walking to
be effective in decreasing pain and improving function
in this population [34]. Hendrick and colleagues simi-
larly presented moderate evidence for walking interven-
tions playing a role in decreasing pain levels in patients
with acute and chronic LBP (CLBP) [22]. However, there
is little standardization between protocols as to the most
effective pedometer-driven walking programs for MSDs,
and therefore it is difficult to evaluate the relative effect-
iveness of one program over another within this popula-
tion. As there has been no systematic review focusing on
the effectiveness of pedometer-driven walking programs
as part of the management of adults with MSDs, the
primary purpose of this systematic review was to investigate
the evidence for pedometer-driven walking programs as an
intervention in promoting PA and improving health-related
outcomes when compared to no intervention, or a different
type of intervention, among adults with MSDs.Mesh terms Musculoskeletal diseases OR “back pain" OR "spinal pain"
OR "knee pain" OR "ankle pain "OR "hip pain" OR
"shoulder pain" OR “osteoarthritis” OR "lower extremity”
OR "pelvic pain" and “Walking”
Keyword “Physical activity”, "aerobic exercise", “Pedometers” and
“step counter”Research question
Does using a pedometer-driven walking program
increase physical activity, and/or improve health in
patients with MSD?Methods
Search strategy
A systematic search of the literature was carried out
using the following electronic databases: MEDLINE,
CINAHL, Embase, Cochrane Library, PubMed, Scopus,
PEDro, Web of knowledge, Sport Discus, AMED, and
Science Direct. All databases were searched from their
inception to 20 February 2014. Keywords and MeSH
terms used in the search strategy were: “musculoskeletal
diseases” OR “osteoarthritis” OR "back pain" OR "spinal
pain" OR "knee pain" OR "ankle pain "OR "hip pain " OR
"shoulder pain" OR "lower extremity" OR "pelvic pain"
AND “walking” OR "physical activity" OR "aerobic exer-
cise" AND “pedometers” OR “step counter” (Table 1). In
addition, the reference lists of all included articles were also
searched for further relevant studies that may not have
been identified by the search strategy described above.
Study selection
The review was conducted in three steps. Firstly, the first
reviewer Suliman Mansi (SM) title-screened all articles
for potential inclusion. The abstracts of those studies
were then independently reviewed by two reviewers (SM
and Paul Hendrick, PH) and consensus sought for ac-
ceptance for review of the full-text article. In the final
step, the references of all full-text articles were searched
for additional articles.
Inclusion and exclusion criteria
Studies were included if they met the following criteria: (1)
randomized controlled trials (RCT) and controlled trials
without randomization published in the English language,
(2) restricted to adults aged 18 years and over with a MSD,
(3) used pedometer-driven walking as an intervention to in-
crease physical activity, and/or improve health outcomes
(physical function, and pain), (4) studies investigating mixed
disorder presentations (MSD as a primary and another
disorder) were also included. Studies that investigated
measurement-validity or reliability- tests of a pedom-
eter walking program were excluded.
Extraction of data
Data extraction for all included studies was performed
by the first author (SM) and cross-checked for consensus
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of publication, study design, objectives, sample and
participants, components of pedometer intervention,
mean steps per day, and outcomes were extracted and
tabulated.
Quality assessment
The methodological quality of the studies included in
this review was assessed using a criteria list that has
been used in previous reviews [44,45]. The criteria list
(Table 2) includes four domain measurements to assess
the quality of the study design (A and B); research popu-
lation (C and D); quality of measurements (E, F, G, and
H); and quality of analysis (I and J). These criteria were
applied, with two reviewers independently evaluating
the methodological quality (SM and PH). The criteriaTable 2 Criteria list for the methodology quality
assessments
Item Description
A Randomization: Is randomization described and adequately
performed? Positive if a random assignment to the research
groups was performed and had been described explicitly.
B Control condition: Is there an adequate control conditions?
Positive if the control group is from that same setting as the
intervention group and (1) an alternative treatment was given, (2)
if there was a comparable condition that controlled for a part
of the intervention, (3) if usual care was given, or (4) if nothing
was done.
C Research groups comparable at commencement: Positive if
the comparability of the research groups was statistically tested
before the start of the intervention and the tests showed that the
intervention group and control group did not differ with respect
to age and at least one of the relevant outcome measures. In
case the groups did differ, positive if this difference was.
D Dropout described and acceptable: Positive if (selective)
dropout was described and when dropout was <20% at short-term
follow-up (6 months or less) and <30% at long-term follow-up (longer
than 6 months.
E Was the person conducting the measurements blind for
group assignment (or was an attempt made at baseline?):
positive if the measurements were conducted by a person blind
for group assignment or if data collection was done with
questionnaires that the respondent could fill out, in a situation
not influenced by the researcher.
F Respondent blind for group assignment: Positive if the
respondent had (or could have had) no knowledge on the results
of the group assignment.
G Timing of measurements is comparable for the different
research groups: Positive if the measurements were conducted
at comparable moments for both the control group and the
intervention group.
H Is the length of the follow-up described and acceptable?
Positive if a follow-up of 6 months or longer was described.
I Intention to treat-analysis: Positive if all initially included and
group-assigned participants are mentioned and analyzed in the
original groups.
J Control for potential confounders: Positive if the analysis
controlled for potential confounders.answer format included positive (+), negative (−), or
unclear (?). Possible scores ranged from 0 to 10; studies
that scored ≤ 5 were deemed to be low quality, and ≥ 6
represented high quality.
To determine the effectiveness of the interventions, a
rating system comprising four levels of evidence was
performed, based on a best-evidence synthesis [46] used
previously for PA interventions [47,48].
 Level 1, strong evidence: multiple RCTs of high
quality with consistent positive results.
 Level 2, moderate evidence: one RCT of high quality
and one or more relevant low quality RCTs.
Consistent positive outcomes of the studies.
 Level 3, limited evidence: only one RCT of high
quality or multiple low quality RCTs. Consistent
positive outcomes of the studies.
 Level 4, no evidence: only one low quality RCT,
negative or contradictory outcomes of the studies,
or no relevant studies.
Results
A total of 1996 articles were retrieved using the search
strategy detailed in the methods section. Based on the
title, 1848 articles were excluded: 323 as duplicate titles
and 1525 did not meet inclusion criteria. One hundred
and forty-eight abstracts were then reviewed, leaving 30
full text articles included for review. Twenty-three of
these manuscripts did not meet the inclusion criteria
and were excluded due to the following reasons: Non-
RCTs (2), protocol study (4), pedometer not part of
intervention (7), and measurement validity/reliability
(10). A total of seven articles met the full selection inclu-
sion criteria (Figure 1). No further studies were identi-
fied from the manual search of the reference lists of
included articles.
Study characteristics
All seven included studies were of a randomized con-
trolled trial (RCT) design and ranged in date of publica-
tion from 1998 to 2013 [49-55]. Three of the studies
were conducted in the United States, [49,51,54] while
two studies were conducted in Japan [52,55] one was
Australian [50] and another study was conducted in
Ireland [53]. The total number of participants across the
seven studies was 484, with an age range of 40 to
82 years. Five of the seven studies included both males
and females [49-51,53,54] while two studies [52,55] re-
cruited females. Sample size ranged from 34 to 229, with
the greatest contribution of 229 participants coming
from Krein et al. [54]. The majority of included studies
examined the effectiveness of a pedometer-driven walk-
ing program to increase PA levels in adults with MSDs.





1525 based on titles
148 based on abstracts
30 Full-text articles reviewed
23 Articles excluded
-Measurement-validity-reliability=10
-Pedometer not part of intervention=7
-No results (protocol)= 4
-Non-randomized=2
7 Articles checked for additional studies 
in reference lists
7 Articles included in this review
Figure 1 Progress through the stages of study selection.
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of a pedometer-driven walking program with goal-
setting versus an education program (no pedometer) by
two registered nurses in 34 participants aged over
60 years, with osteoarthritis of the knee. Participants in
both the walking intervention and control groups re-
ceived a 12-hour education arthritis self-management
program including 1 hour of information on exercise for
coping with arthritis. Participants in the intervention
group also received a pedometer, step goals, feedback,
and an education booklet. Outcome measurements were
evaluated at baseline, week 12 and week 24.
Ng et al. [50] compared the effectiveness of two differ-
ent pedometer-driven walking program interventions
called ‘Stepping Out’ on osteoarthritis symptoms of the
hip and knee in 36 patients aged between 42 and
73 years, over a 24-week period. The first group (A)
received a pedometer walking program three times per
week plus glucosamine sulphate (GS) intake, and the
second group (B) received a pedometer-driven walking
program undertaken five times per week plus GS intake.
Both groups received GS intake alone for 6 weeks beforethe Stepping Out program commenced. By the sixth
week session, participants were asked to initially walk at
least 1500 steps per day, and gradually increase their
steps from 1500 to 3000 steps per day by the week 12
assessment. From the twelfth week, participants were
asked to increase their walking to 6000 steps per day
until the eighteenth week. Participants in group (B) re-
ceived the same program and procedures with the same
goals, but were asked to walk five days per week
(Table 3). Between week 18 and the 24 week follow-up,
participants were instructed to continue with either the
walking program or to try another PA as an option. Re-
sults were reported at week 6, 12, 18 and the 24-week
follow-up.
Fontaine and Haaz [49] examined the effects of a ped-
ometer walking program on health status, pain, and PA
in low-active adults with fibromyalgia syndrome (FMS).
Forty-eight participants aged 18 years or older diagnosed
with FMS were randomized into one of two groups: a
pedometer based intervention group or a control group.
The pedometer based intervention group included a 90-
minute cognitive-behavioral PA program (which provided
Table 3 Intervention design




Walking up to 3000
steps per day plus GS
Walking up to 6000
steps per day plus GS
Any PA
choice
GS: glucosamine supplements, PA: physical activity.
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monitoring) every two weeks for 12 weeks. At the first
week, participants were asked to wear the pedometer dur-
ing waking hours and to record daily step counts, while
walking 10 min per day five to seven days per week, and to
gradually increase daily duration of walking by five minutes
every week. The control group received a 90 min fibro-
myalgia education program once a month over a three
month period, including information on the symptoms,
diagnosis, exercise and PA, and treatment for FMS, without
wearing pedometers.
Toda et al. [52] examined the effects of a weight loss
program for improving symptoms of OA in obese pa-
tients with knee OA. They investigated a number of var-
iables in the weight control program (including weight,
total cholesterol, triglycerides, blood glucose, serum
levels of insulin, and PA by pedometer) to determine if
any of these factors were associated with symptomatic
relief of knee OA symptoms. Both groups received non-
steroidal anti-inflammatory drugs (NSAIDs) alone for
4 weeks before the study. The intervention group then
received 0.5 mg Mazindol once per day plus NSAID
medication twice a day, with 150 ml low calorie soup
given at both breakfast and lunch for 6 weeks; in
addition this group was instructed to wear a pedometer
and to walk for 30 minutes each day for 6 weeks, during
both work and leisure time. The control group received
the same NSAIDs as the intervention group for 6 weeks,
and a pedometer walking program without any specific
instructions. McDonough and colleagues [53] examined
the feasibility of a pedometer walking program with edu-
cation advice increasing physical activity in patients with
CLBP. The study randomized 57 patients to a pedometer
intervention group (n = 40) or to a control group (n = 17;
education advice). All participants attended a one-hour
session on education advice and completed a 10 minute
self-efficacy walk at week one. Participants in the interven-
tion group received a pedometer for 8 weeks, with individ-
ual step goals, feedback, regular contact, and education
advice. Results were reported at baseline, week 9 and
6 month follow-up.
Krein et al. [54] examined the effect of a pedometer-
based internet-mediated intervention on reducing CLBP
at 6 and 12 months for 229 patients who were divided
into an intervention group (n = 111) and a control group
(n = 118). The intervention group received uploading pe-
dometers and access to the intervention website whichincluding goal setting, feedback, motivational messages,
and social support following the Stepping Up to Health
program. The control group also received pedometers
but without goals or feedback. Lastly, Hiyama et al. [55]
randomized 40 patients with knee osteoarthritis to a
walking group including pedometer (n = 20) or a control
group (n = 20) for 4 weeks. All participants attended
physical therapy once a week, and completed exercises
for muscle strengthening and range of motion every day
at home. The walking group received instructions to in-
crease their steps to 3000 steps more than baseline value
and record their steps every day. Outcome measurements
were evaluated at the week before the intervention started
and at week four of the intervention (see Table 4).
Methodological quality assessment
Methodological quality scores are shown in the Table 5.
There was 100% agreement between the two reviewers’
independent evaluation scores. The quality scores achieved
ranged from 3 to 10 with five studies scored ≥ 6 out of 10
as a high quality score [50,51,53-55], and two studies
scored ≤ 5 out of 10 [49,52] as low quality scores. One
study achieved a maximum quality score [54], and five
studies failed to score on the double blinding items
(E and F); this may be due to the nature of the
interventions.
Pedometer intervention
From the seven pedometer walking interventions reported
among patients with MSDs, four interventions focused on
improving knee osteoarthritis patients [50-52,55] while two
interventions [53,54] targeted CLBP patients, and one inter-
vention [49] focused on fibromyalgia patients. The duration
of the interventions ranged from 4 weeks to 12 months,
with several walking protocols including the Stepping Up
to Health program, [50,54] cognitive dual-tasks perform-
ance, [55] the 5As model of behavior change, [53] active
living every day, [49] and the walk + program [51] as the
framework for the interventions. However, the majority of
those were based on Social Cognitive Theory [56] which
involves using behavioral strategies such as goal setting,
problem solving, self-efficacy, and social support to pro-
mote PA or to provide information on the benefits of walk-
ing to health or feedback and also to provide individual
specific step goals. In all interventions, participants were
instructed to use pedometer driven walking at least three
times per week. The drop-out rate between baseline and
post-intervention varied between 7.5% and 29.0% except
one study reported no dropouts [55]. Reasons for drop-out
included death, increased pain, scheduling conflicts, and
forgetting to attach the pedometer for several days. All
intervention studies provided information on the amount
of steps per day before and after the intervention except for
Toda et al. [52]. In addition, different pedometer models
Table 4 Studies that used pedometers as an intervention for musculoskeletal diseases









on OA symptom and






From 0 to 6 weeks both
groups received GS.
between week 6




groups in step/day/(P = .07).
Significant improvements in
pain (P = .001) and physical
function (P = .001) for both
groups
Group A: From 7 to12 weeks
received GS + pedometer
and walking up to 3000
steps/day
- Group A n = 19
(walking 3 days /week)
Ng et al. [50]
From 13–18 weeks received
GS + pedometer and walking
up to 6000 steps/day Group




-Group B n = 17
(walking 5 days/week )
program lasted
12 weeks
RCT To determine whether a
pedometer program with
arthritis self-management
would increase PA and
muscle strength in subject
with OA of knee.
−34 participants with
knee OA (age = 60 and
older)
Both groups received
12 hours arthritis self-
management education




between groups in PA
(P = .04), and muscle
strength (P = .04) with no






instruction to increase their
step count by 10% every
4 weeks from their baseline
step count with feedback
and exercise materials.











RCT To compare pedometer
program vs. an education
program on health status
and PA levels in adult with
Fibromyalgia syndrome (FS).




90 min cognitive behavioral
program × 2 per weeks for
12 weeks. from week 1
participants were asked to
increase 10- min walking
every week to reach 30 min
by week 5 control group:
received 90 min cognitive
behavioral program once a





Significant increase in PA
for intervention (P = .001).
No significant differences
between groups in pain
(P = .060), fatigue (P = .85)






-pedometer n = 22





RCT To determine the variable





group n = 22 control
group n = 18 The
program lasted
6 weeks
Both groups received drugs







between groups in steps
(P = 0.86) at 6 weeks.
Correlation significant
between steps and
relief pain (P = .003)
Intervention group: received
0.5 mg Mazindol once per
day plus the NSAID twice a
day, and instructed to wear a
pedometer to walk 30 min
each day for 6 weeks
relief of OA of knee in





Control group: received same
the intervention group but




RCT To examine the feasibility







Both groups received a





increased their step count
from baseline by 2776
(95% CI, 1996–3557) and
improvements in pain score
(ODQ) by 8.2% (CI, −13-3.4)
at 6 weeks
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Pedometer group: in week
1, 10 min self-efficacy walk
completed. Week 2, meeting
to provide step target,
between week 3 and 8 weekly
phoned to discuss
the progress. This program
was based on 5A,s framework
including 1. ask/assesses
barriers to PA, 2. advise to
increase PA, 3. change walking
goals, 4. address barriers with
feedback, 5. regular feedback.
























between groups in steps
at 6 and 12 months
respectively (P = .12,
and P = .08).
Significant difference
between groups in RDQ
scores (P = .02) at 6 month,
and non-significant at
12 months (P = .07)
Intervention n = 111
Krein
et al. [54]














Both groups attended one
session of physical therapy
once a week, and also
received ice therapy,
exercises for range of
motion and muscle strength




Significant increase in PA
for intervention (P = .001).
Participants in intervention
group significantly improved
their functional disability and




Walking group n = 20







In addition, walking group
received pedometer with
instruction to increase their
steps to 3000 steps more
than their baseline
Control group n = 20
(age 73.8 ± 5.7)
program lasted
4 weeks
PA: physical activity, OA: osteoarthritis, GS: glucosamine sulphate, NSAID: nonsteroidal anti-inflammatory drugs, ODQ: Oswestry Disability Questionnaire, CLBP:
chronic low back pain, RDQ: Roland Morris Disability Questionnaire.
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walker DW-701 [53]; Seiko, Tokyo [52]; Omron HJ-
720ITC [54]; Kenz Lifecoder [55]; and Accusplit® Eagle
Activity Pedometer [49]) as a motivational tool for in-
creasing PA and as a measurement tool across all seven
studies; the details of models are shown in Table 4.
However, the majority of included studies did notTable 5 Methodological quality assessment scores for the
included studies
Study A B C D E F G H I J Total
Ng, Heesch et al. [50] + + + + - - + + + ? 7
Talbot et al. [51] + + + + - ? + - + - 6
McDonough et al. [53] + + + + - ? + + + + 8
Krein et al. [54] + + + + + + + + + + 10
Hiyama et al. [55] + + + + + + + - - + 8
Fontaine and Haaz [49] ? + + - ? ? + - ? ? 3
Toda et al. [52] ? + + + + ? + - - ? 5
A: Randomization, B: Control condition, C: Research groups comparable at
commencement, D: Dropout described and acceptable, E: measurements
blinded, G: Respondent blinded, H: length of the follow-up, I: Intention to
treat-analysis, J: Control for potential confounders.provide details regarding the validity and reliability of
the pedometers or describe the instructions about how
pedometers were used.
Effect of interventions on physical activity levels
All studies showed positive findings for using a pedom-
eter to increase the level of PA over the intervention
periods (Table 6). Five out of seven studies showed sta-
tistically significant improvements in step count in the
intervention group relative to baseline (5/7: 71%; p < 0.05).
Four of these studies had high methodological quality
scores [50,51,53,55] and one had a low quality score [49].
However, the majority of studies used pedometers for
goal-setting to increase the daily PA level. The pedom-
eter goal-setting regime utilized by Talbot et al. [51] re-
sulted in significantly increased (p = 0.040) step counts
from baseline (from a mean 3519 steps per day to 4337
steps per day after 12 weeks) in the pedometer group
compared to control, and no decreases in activity at
the 24-week follow-up. Ng et al. [50] reported an
increase in PA (number of steps per day from 3920 to
6683) over the 12 weeks in both pedometer-driven
Table 6 Pedometer data at baseline and after intervention
Study Pedometer intervention Control group
Baseline Post-test MD Baseline Post-test MD
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Talbot et al. [51] 3519(2603) 4337(2903) 818 4652(2622) 3972(2563) −680
McDonough et al. [53] 5563((N/R) 8339(N/R) 2776 (N/R) (N/R) (N/R)
Fontaine and Haaz [49] 2337(427) 3970(598) 1633 (N.P) (N.P) (N/R)
Toda et al. [52] (N/R) 7500(N/R) (N/R) (N/R) 7300(N/R) (N/R)
Hiyama et al. [55] 4453(1734) 7285(1638) 2829 4425(1627) 4207(1436) −218
Ng et al. [50] 2 N 3920(2441)٭ 6683(3403) 2763 (N.C) (N.C) (N/R)
Krein et al. [54] 4492(2749) 5370(3180) 877 4322(2285) 4682(2925) 360
2 N = two intervention groups ٭= for both intervention groups, N/R = not reported, N.C = no control group, N.P = pedometer not applied, SD = Standard Deviation,
MD =Mean difference.
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and Haaz [49] also found the pedometer-driven lifestyle
PA group significantly increased PA levels (P = 0.001) (daily
steps increasing from 2337 to 3970) at 12 weeks post-
intervention in the intervention group, with no step count
data available for the control group.
McDonough et al. [53] showed an increase in daily
steps taken of 2776 on average in the intervention group
over 8 weeks, but no step count data was reported for
the control group. A similar increase was reported by
Hiyama et al. [55], who recorded a mean difference of
2832 steps per day in the intervention group after
4 weeks of intervention, which was significantly greater
than in the control group (p < 0.001). In addition, Krien
et al. [54] reported that daily step counts increased by an
average of 878 steps per day within the intervention
group compared to an average of 361 steps per day for
the control group after 6 months of intervention, but
this difference was not statistically significant.
Overall, results from across six studies reported that
PA, assessed by walking, significantly increased by an
average of 1950 steps per day (ranging from 818 to 2829
steps) over baseline assessment. However, it should be
noted that this result is simply an average of the mean
increases across six studies; individual results varied
markedly.
Effect of interventions on health benefits
For secondary outcomes in this review, we found the
majority of studies reported results on functional per-
formance and pain scores. While there was a variety of
measures used to assess disability and pain in these stud-
ies, the majority indicated an improvement in physical
function, pain, or other health variables (fatigue, anxiety
and depression) following the intervention [49-51,53-55].
Four of these studies showed a statistically significant im-
provement in disability and pain scores [50,51,54,55] in the
intervention groups. Krein et al. [54] found that a pedom-
eter driven walking program significantly decreased backpain-related disability as recorded by the Roland Morris
Disability Questionnaire (RDQ) (p = 0.02, MD= 1.6, 95%
CI, 0.3-2.8) compared with a control group at 6 months
post-intervention. Similarly, Ng et al. [50] reported that the
mean scores of the Western Ontario and McMaster
University (WOMAC) and Osteoarthritis Index numeric
rating scale (NRC) significantly improved (p = 0.001) in
both groups between week 6 and the final follow-up points,
with no significant difference reported between the groups
in any outcome measure at any assessment point.
Hiyama et al. [55] used the Japanese Knee Osteoarthritis
and Automaticity Index measures to assess participants’
functional disability and pain. The study reported signifi-
cant improvements in automaticity (p < 0.001) from base-
line to post-intervention for the walking group. Functional
performance, muscle strength, and pain were also mea-
sured by Talbot [51] who reported a significant increase in
quadriceps femoris muscle strength (p = 0.040) and func-
tional performance (p < 0.050) in the intervention group
following the intervention, with no significant difference in
pain scores. McDonough et al. [53] reported a greater
reduction in levels of disability (Oswestry Disability
Questionnaire; ODQ) by −5.5 points (95% CI, −8.8
to −2.2) for the intervention group compared with
participants assigned to the control group ( −1.0, 95%
CI, −7.6 to −5.6). Toda et al. found a significant correl-
ation between the number of steps per day and increasing
symptomatic relief of knee OA pain (p = 0.003, r = −0.58)
and decreasing body fat (p = 0.012, r = −0.62) [52].
Discussion
The primary aim of this review was to identify the
effectiveness of pedometer-driven walking programs in
increasing levels of PA in patients with MSDs. Seven
studies were identified which examined the effectiveness
of pedometers to increase PA levels and improve phys-
ical function and pain in the short term. The majority of
studies included in this review reported significant in-
creases in PA (p < 0.050) following the intervention, with
Mansi et al. BMC Musculoskeletal Disorders 2014, 15:231 Page 9 of 13
http://www.biomedcentral.com/1471-2474/15/231a mean positive change in PA of 1950 steps per day over
the intervention period, and improved scores for pain
and physical function after the intervention. This represents
strong evidence (level 1) for the effectiveness of pedometer
walking interventions for promoting PA levels in these pa-
tient populations. Evidence was appraised and synthesized
based on the consistently positive results and high meth-
odological quality of studies included in this review [44,46].
Interventions and physical activity levels
It appears that pedometer based walking interventions
with a combination of behaviour strategies are effective
to increase PA behaviour among MSD populations. The
majority of studies included in this review used a num-
ber of strategies to maintain the increased levels of PA
within the intervention programs. These generally con-
sisted of a range of goal setting strategies, and cognitive-
behavioral approaches. For example, the study by Talbot
et al. [51] reported an increase in the level of PA by 23%
compared to a 16% decrease in steps in the control
group. Such reported increases may be due to the tar-
geted step goals employed, whereby participants were
instructed to increase walking by 10% every 4 weeks
above their baseline value. It may also be that giving
feedback to patients on an individual basis and the
provision of reading materials also supported the effect-
iveness of the intervention. These findings are consistent
with previous studies targeting non-MSD conditions, in-
cluding type 2 diabetes, acute coronary syndrome, and
inactive populations [35,36,38,57-59] that demonstrate
positive effects for a range of pedometer-driven walking
interventions combined with cognitive-behavioral strat-
egies to increase PA levels and quality of life.
Data from other studies included in this review also
report similar or higher increases in PA levels after the
intervention [49,50,53,55]. This finding is reflective of
evidence from previous studies which suggests that com-
bining pedometer-driven walking programs with goal set-
ting [36,38,60] or cognitive behavioral strategies [57-59] is
more effective than pedometer-driven walking alone in
adult outpatients. A case study that investigated a pedom-
eter walking intervention in patients with OA [60] showed
that incorporation of goal setting into the program was ef-
fective in increasing PA levels. These findings are consistent
with a recent meta-analysis of randomized controlled trials
assessing promotion of PA within sedentary adults in pri-
mary care which reported the positive impact of physician
counselling, written materials and advice sessions on in-
creasing physical activity levels at 12 months [61].
The daily increase in step count between baseline and
following the intervention varied across included studies.
The step-count increase ranged from 818 to 2829 steps
per day over the intervention, with interventions ranging
from 4 weeks to 12 months. Such variability may be areflection of the range of conditions and populations,
CLBP [53,54], hip and knee OA [50-52,55] different
country settings, and accuracy of the pedometers used.
For future study, attention must be taken regarding the
validity of pedometers for disabled populations, and in
particular factors which potentially impact on the meas-
urement of the number of steps taken during the inter-
vention, such as pedometers that are not accurate at low
speed walking [62]. Consistent with an early systematic
review exploring the validity of pedometers [63] which
reported that patients with disability are likely to have
slower walking speeds compared to healthy controls. In
addition, the reliability and validity of several pedometer
models were examined in the literature [64,65] and they
found the Yamax Digi-walker series pedometers (Yamax
DW200 and 701, Kenz Lifecorder (KZ), New-Lifestyles
NL-2000 (NL), and Omron (OM)) were the most suitable
for measurement of PA in research studies; recording 1-3%
error of actual steps taken at different walking speeds.
Thus, choosing appropriate pedometers for these popula-
tions and determining the optimal pedometer placement is
necessary to avoid methodological limitations.
The majority of studies included in this review used
walking pedometer interventions in one trial arm that
aimed at increasing PA levels in the short term, follow-
ing a commonly applied PA recommendation: [10,66,67]
i.e. involving moderate intensity activities such as walk-
ing, three to five times per week, for 30 to 60 min per
session. It is significant that patients with MSDs in these
studies were encouraged to meet the minimum recom-
mended levels of PA for health related benefits [27,68].
The mean step count following the intervention ranged
from 3970 to 8339 steps per day across the six studies,
with an average of ≈ 5996 steps per day. The average in-
crease of 1950 in step-counts represents more than 32%
increase above baseline (range 20% to 70%), and such incre-
ments are equivalent to approximately 20 minutes walking
per day. Importantly, this increase in step count was suffi-
cient to enable participants to meet the minimum recom-
mended levels of PA [66] of between 3500 to 5500 steps
per day for people with physical disabilities [66].
Although two studies [49,53] reported significant in-
creases in the number of steps after the intervention,
they failed to report baseline and post-intervention step
counts for the control group which precludes further
evaluation and comparison of groups. A further study
[50] also reported an increase of 2763 steps over
12 weeks of the Stepping Out program in both interven-
tion groups, with no significant difference in the number
of days per week spent walking between groups (3.07 ±
0.82 and 3.93 ± 1.09 mean days per week respectively).
Thus, it appears that participation in walking either
three days or four days per week were effective for in-
creasing PA and reducing pain in this population. This
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tients with hip or knee OA is between two to four days
per week in order to increase PA and improve health-
related outcomes [69-71]. Equally, it may be difficult to
ask such patients to walk more than three days per
week, as most patients with hip or knee OA have
inactive lifestyles and are three times more likely to have
difficulty walking [72]. However, walking three days per
week may be advantageous for people with pain and
disability, allowing them time for recovery during the
rest times within the week.
People living with disability such as MSDs are usually
classified as a low activity population [73], which may be
deleterious to their health and affect their ability to walk
if the sedentary behavior is sustained [73]. In this review
we observed that all studies reported a low number of
steps at baseline ranging from 2337 to 5563 steps per
day, except one study with no assessment at baseline
reported [52]. This mean steps/day places these partici-
pants within the low active category (<5000 steps per
day) [74]. The increase in step count following the ped-
ometer driven intervention in these studies is a reflec-
tion of an inactive population significantly improving
their PA [75] and potentially indicates that a cognitive-
behavioral PA program may be a key motivational factor
for increasing PA behavior. These findings suggest that
pedometer based interventions in combination with be-
havioural strategies are effective in PA behaviour change
(short-term) to motivate and track progress of their
steps. This finding is consistent with a systematic review
which found evidence to support the efficacy of behav-
ioural interventions for promoting PA to sedentary
adults in primary care [61].
Interventions and health benefits
Previous research has shown that physical activity inter-
ventions improve overall health, with overall reduced
general risk of premature mortality, [10] decreasing pain,
and improving function with disability [34] across all
groups and both sexes in the general population. Based
on our data, significant improvements in disability and
pain scores [50,51,54,55] were reported in the interven-
tion groups. Talbot et al. [51] reported a 21% increase in
quadriceps femoris muscle strength in the intervention
group compared to a 3.5% decrease in the control group.
This result may in part be due to an increased step
count in the intervention group and also potentially as a
result of the 10% reduction in pain; however, there were
no significant differences between the two groups for
pain and physical function.
One study [52] reported that the number of steps per
day was significantly correlated with symptomatic relief
of knee OA pain and body fat loss after the intervention.
This result may be due to the observed relationshipbetween reductions in obesity levels and improved pain
of knee OA [76,77] and is also consistent with a meta-
analysis of pedometer-based walking interventions that
reported a weight loss of 1.27 kg (95% CI, 1.85 to 0.70 kg)
through increasing PA in the short term, with more weight
loss correlated with longer programs [78]. Furthermore,
a number of previous studies have shown a clear link
between increased PA and weight reduction, with symp-
tomatic relief of knee OA pain [79-81].
Step count improvements were also correlated with a
reduction in back pain related disability, symptoms of
anxiety and depression, fatigue, and six-min walk dis-
tance in the short term [49,53,54]. These results are con-
sistent with many similar walking intervention studies
[19,34,60,68,82,83] that demonstrated a positive effect of
increased PA on pain and health-related outcomes in
subjects with MSDs. Future studies are required to es-
tablish these findings within large powered clinical trials.
This review found strong evidence (level 1) for the
effectiveness of pedometer walking interventions in in-
creasing PA levels for patients with MSDs. Future research
of high methodological quality with larger sample sizes is
needed to investigate the effectiveness of pedometer-driven
walking for improving PA and health-related outcomes in
patients with MSDs. Such research is already underway:
recently, two protocols have been published for controlled
studies on patients with LBP using pedometer-driven
walking programs [42,43] in order to reduce pain-related
disability and functional limitation.
Study limitations
This study has a number of limitations: variation in meth-
odology, outcome measures, statistical methods and study
subjects in the reviewed studies preclude a formal meta-
analysis of the available data. We used four key elements of
the design of the included studies to assess heterogeneity:
the patients, interventions, outcomes and methods.
Therefore, a narrative systematic review was conducted
displaying information retrieved from the seven studies
included in this review.
We also restricted our search to full–text articles in
the English language, as well as the use of a limited key-
word search and excluded doctoral theses and confer-
ence abstracts. This may have resulted in some relevant
studies being missed. In addition, we calculated the
mean number of steps as simply an average of the mean
increase across six studies. Interpretation of the data and
generalization of the findings should be considered; indi-
vidual results varied markedly. Based on the data, the
majority of studies included in this review also provided
education programs such as: information on the benefits
of PA, arthritis self-management program, LBP back
book, and receiving medication to relieve their pain.
These components may also have changed (increased)
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health outcomes.
The studies that we identified used a variety of differ-
ent pedometer brands; however, the majority did not re-
port sufficient information on the validity and reliability
of pedometers used. The majority of studies included in
this review mentioned the name of pedometers without
providing any details on the validity and reliability of
pedometer used. Several studies have been conducted to
examine the validity and reliability of various pedome-
ters under a variety of conditions to define the most ac-
curate brand in adult populations. A study of adults [64]
that compared thirteen models of pedometers under
free-living conditions reported that the validity and reli-
ability differed. We believe that the lack of information
on the psychometric properties of the pedometers may
have affected the report of step count levels, and hence
the interpretation of physical activity.Further research direction
Future research should explore the long-term effective-
ness of pedometers in increasing PA levels in these pop-
ulations. The majority of the studies included in our
review included short term follow up, highlighting the
necessity of longer term studies. Pedometer-driven walk-
ing interventions also need to be compared as single
interventions, and ideally against current best treatments
for patients with MSDs within an RCT design.Conclusions
This review showed that the majority of studies reported
a positive change in PA, providing strong evidence for
the effectiveness of pedometer walking interventions in
increasing PA levels for patients with MSDs. Improve-
ments in physical function and pain scores were also
noted in these study populations. It would appear that a
combination of interventions using the pedometer, under-
pinned by cognitive-behavioral approaches to behavior
change, are likely to be more effective in increasing PA than
the use of a singular intervention approach, which is con-
sistent with recommendations from previous systematic
reviews. Further research is required to support the role of
pedometer walking interventions as a long term interven-
tion for management of MSDs.Competing interests
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